Sigma Planning Corp - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$3,536
-29.3%
32,0000.0%0.00%
Q3 2022$5,000
-37.5%
32,0000.0%0.00%
Q2 2022$8,000
-52.9%
32,0000.0%0.00%
-100.0%
Q1 2022$17,000
-15.0%
32,0000.0%0.00%0.0%
Q4 2021$20,000
-39.4%
32,0000.0%0.00%0.0%
Q3 2021$33,000
-44.1%
32,0000.0%0.00%
-50.0%
Q2 2021$59,000
-6.3%
32,0000.0%0.00%0.0%
Q1 2021$63,000
+57.5%
32,0000.0%0.00%
+100.0%
Q4 2020$40,000
-31.0%
32,0000.0%0.00%
-50.0%
Q3 2020$58,00032,0000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders